H pylori seroprevalence in patients with lung cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

206

HTML

1742

Tables (1-2)

151

Sum=2099

Apr 28, 2007 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Apr 28, 2007; 13(16): 2349-2351
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2349

Table 1 Mean (SD) characteristics of the study cases and controls

Variables	Cases	Controls	P¹
	(n = 40)	(n = 40)	P¹
Sex (M/F)	32/8	25/15	0.03
Age (yr)	55.50 (11.91)	43.08 (12.60)	> 0.05
H pylori IgG level (U/mL)	1.37 (0.74)	1.07 (0.44)	> 0.05
H pylori serology²			0.65
Positive for IgG antibodies to H pylori	21 (52.5)	18 (45.0)
Negative for IgG antibodies to H pylori	13 (32.5)	17 (42.5)

¹All P values are for 2-tailed t tests.

²Six case subjects and 5 control subjects had borderline results and were excluded from the study.

Citation: Najafizadeh K, Falah Tafti S, Shiehmorteza M, Saloor M, Jamali M. H pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2007; 13(16): 2349-2351
URL: https://www.wjgnet.com/1007-9327/full/v13/i16/2349.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i16.2349